Equal benefits to our residential courses, without the travel.View Courses
All our courses. 12 months access. One flat fee.More Information
Non-members can signup to keep up to date with RQA news and events.Add your details now
10th March 2022
EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines that address patients’ unmet medical needs. The time to marketing authorisation was reduced for medicines that benefitted from PRIME support, giving patients earlier access to transformative treatments that can make a real difference to their health.